Fdabaa-24-00123: development of modernized susceptibility guidance for nitrofurantoin dosing using a dynamic urinary tract in vitro infection model and pharmacometric approaches - FY24C3BP4
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40124C00080
- Awardee
-
Institute For Clinical Pharmacodynamics, Inc. UEI Z82HHPY83MC7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $248,553
Award facts
- Opportunity
-
- FY24 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Pre-Solicitation · FDABAA2400123 · Posted Oct 2, 2023
- Contract value 100% obligated
- $248,553.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Schenectady, NY 12305, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $248,553 |
About this award
The Food and Drug Administration awarded a $248,553.46 definitive contract to Institute For Clinical Pharmacodynamics, Inc. for development of modernized susceptibility guidance for nitrofurantoin dosing using dynamic urinary tract in vitro infection modeling and pharmacometric approaches on August 19, 2024.
The award stems from an FDA Broad Agency Announcement soliciting advanced research and development proposals to support regulatory science, with a two-stage review process (concept paper due November 6, 2023; full proposal due February 19, 2024). The contract is firm fixed price with no set-aside applied. Place of performance is Schenectady, NY. The contract completion date is October 29, 2025. The primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences).
Quick answers
Who was awarded contract 75F40124C00080?
75F40124C00080 was awarded to Institute For Clinical Pharmacodynamics, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 19, 2024.
How much is contract 75F40124C00080 worth?
The government has obligated $248,553 on 75F40124C00080.
Was contract 75F40124C00080 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award